Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Is Kursana a Cinderella?

Dussmann, the big European facilities management company which also owns Kursana, the fifth largest German nursing home group, saw revenue grow 20% to €2.8 billion in 2022. The company claimed that this was “almost exclusively organic.” But the Care & Kids division which is mainly Kursana didn’t grow at all. Is it a Cinderella?
May 16, 2023

UPMC continues Irish expansion

US-based multinational hospital group UPMC (University of Pittsburgh Medical Centre) has bought Irish sports medicine hospital Sports Surgery Clinic. It is the US group’s fourth hospital in Ireland.
May 15, 2023

Babylon to be taken private by creditors

Shareholders in Babylon, which was worth $4.2bn at listing in October 2021, face being wiped out as it reverts to private ownership as creditor Albacore takes over. CEO and founder Ali Parsa, whose remuneration totalled $7.1m in 2022, is likely to stay on, says a legal expert who says the group could face legal action.
May 12, 2023

€1bn+ German outpatient group sale to shake up market

German out-of-hospital intensive care provider Deutsche Fachpflege is reportedly up for sale, in a deal that could value the company in excess of €1bn. HBI understands other players in the sector may also be coming up for sale in the coming months.
May 12, 2023

IK Partners to take UK teleradiology provider Medica private

Listed UK-based teleradiology provider Medica is being taken private by PE firm IK Investment Partners, which has made an offer of £269m to buy all of the group’s shares. Medica has accepted the offer, which was 32.4% higher than the group’s average market cap over the past three months.
April 28, 2023

Temasek buys $2bn additional stake in Manipal

Singaporean state-owned investment conglomerate Temasek is to become majority shareholder in Manipal Hospitals, one of India’s largest hospital chains, as it increases its stake from 18% to 59%.
April 21, 2023

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 
April 19, 2023
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us